AVDL - Avadel Pharmaceuticals plc (AVDL) CEO Gregory Divis on Q2 2021 Results - Earnings Call Transcript
Avadel Pharmaceuticals plc (AVDL) Q2 2021 Earnings Conference Call August 09, 2021, 08:30 AM ET Company Participants Courtney Turiano - Investor Relations Gregory Divis - Chief Executive Officer Tom McHugh - Chief Financial Officer Richard Kim - Chief Commercial Officer Jennifer Gudeman - Vice President of Medical and Clinical Affairs Conference Call Participants Paul Matteis - Stifel David Amsellem - Piper Sandler Francois Brisebois - Oppenheimer Oren Livnat - HC Wainwright Robin Garner - Craig -Hallum Matthew Kaplan - Ladenburg Thalmann Jason Gerberry - Bank of America Presentation Operator Greetings and welcome to Avadel Pharmaceuticals Second Quarter 2021 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Courtney Turiano. Thank you. You may begin. Courtney Turiano Good morning and thank you for
For further details see:
Avadel Pharmaceuticals plc (AVDL) CEO Gregory Divis on Q2 2021 Results - Earnings Call Transcript